Impact of circulating cholesterol levels on growth and intratumoral androgen concentration of prostate tumors - Test2 - elhamkhani - TriplyDB

Impact of circulating cholesterol levels on growth and intratumoral androgen concentration of prostate tumors

Impact of circulating cholesterol levels on growth and intratumoral androgen concentration of prostate tumors

http://www.wikidata.org/entity/Q34141720

about

The relationship between nutrition and prostate cancer: is more always better?Persistent androgen receptor addiction in castration-resistant prostate cancer Obesity and cancer: mechanistic insights from transdisciplinary studies Steroidogenesis in the skin: implications for local immune functions Abiraterone in the treatment of metastatic castration-resistant prostate cancer Metabolic profiling of cholesterol and sex steroid hormones to monitor urological diseases Nutrition, dietary interventions and prostate cancer: the latest evidence Evaluation and prognostic significance of ACAT1 as a marker of prostate cancer progression Identification of CETP as a molecular target for estrogen positive breast cancer cell death by cholesterol depleting agents Hypercholesterolemia induces angiogenesis and accelerates growth of breast tumors in vivo.Intratumoral steroidogenesis in castration-resistant prostate cancer: a target for therapy.The response of the prostate to circulating cholesterol: activating transcription factor 3 (ATF3) as a prominent node in a cholesterol-sensing network Key role of CRF in the skin stress response system.Serum lipid profile and risk of prostate cancer recurrence: Results from the SEARCH database High incidence of prostate cancer metastasis in Afro-Brazilian men with low educational levels: a retrospective observational study.Association of serum lipid levels and prostate cancer severity among Hispanic Puerto Rican men Racial Differences in the Association Between Preoperative Serum Cholesterol and Prostate Cancer Recurrence: Results from the SEARCH Database.New players for advanced prostate cancer and the rationalisation of insulin-sensitising medication SULT2B1b sulfotransferase: induction by vitamin D receptor and reduced expression in prostate cancer.Apolipoprotein E gene polymorphism influences aggressive behavior in prostate cancer cells by deregulating cholesterol homeostasis.Epidemiology and molecular mechanisms tying obesity, diabetes, and the metabolic syndrome with cancer.AR-Signaling in Human Malignancies: Prostate Cancer and Beyond.Lipids and prostate cancer.LXR, prostate cancer and cholesterol: the Good, the Bad and the Ugly.The fat side of prostate cancer.The role of cholesterol metabolism and cholesterol transport in carcinogenesis: a review of scientific findings, relevant to future cancer therapeutics.Steroid hormone synthetic pathways in prostate cancer.Diet-induced hypercholesterolemia promotes androgen-independent prostate cancer metastasis via IQGAP1 and caveolin-1 Effects of cholesterol, C-reactive protein, and interleukin-6 on prostate cancer risk in a population of African ancestry.Evidence for Feedback Regulation Following Cholesterol Lowering Therapy in a Prostate Cancer Xenograft Model.Statin Use, Serum Lipids, and Prostate Inflammation in Men with a Negative Prostate Biopsy: Results from the REDUCE Trial.Targeting persistent androgen receptor signaling in castration-resistant prostate cancer.The current evidence on statin use and prostate cancer prevention: are we there yet?The emerging role of obesity, diet and lipid metabolism in prostate cancer.Low-density lipoprotein receptors play an important role in the inhibition of prostate cancer cell proliferation by statins Oral simvastatin administration delays castration-resistant progression and reduces intratumoral steroidogenesis of LNCaP prostate cancer xenografts.Is PSA related to serum cholesterol and does the relationship differ between black and white men?Cholesterol Sulfonation Enzyme, SULT2B1b, Modulates AR and Cell Growth Properties in Prostate Cancer.Differential ontogenetic exposure to obesogenic environment induces hyperproliferative status and nuclear receptors imbalance in the rat prostate at adulthood.Metabolic syndrome, dyslipidemia and prostate cancer recurrence after primary surgery or radiation in a veterans cohort.

P2860

Q24604956-50BE6D78-45A8-4707-A94F-1792A50CAE71 Q26777163-F1E5DA78-1A19-41CE-ADF2-3F51593950D1 Q26786829-AC665FBD-0FE2-4D0B-B967-39753C8697D7 Q26830355-33512CC8-2D30-4FB5-9D72-54228052E4B0 Q26853635-F8619402-2EE4-49F2-8445-EAD4A085716B Q28079470-303700B4-73EA-49C5-92E7-D428C19C5A0A Q28084566-3E6D1B65-A9E3-44EE-B9B5-F01B1B67004E Q28303423-59AF1538-508B-45CB-A6B6-8B918CD755C9 Q28821083-95CA82A1-C128-4D0F-9A15-CA8E1C0B90F7 Q33826605-5399EA29-E8FD-4FCD-8150-4CD510753D7E Q34294888-0C9CEDE2-3B5D-428E-A01E-6D6EB1A15707 Q34328954-F74F1FFF-6DD1-428D-AD7D-A802BE753DFE Q34363640-447E94D2-7222-4DB1-B3B3-E0DE63A5FCBD Q34458822-DD1642E5-9D05-484C-96D6-0118C4802763 Q34756185-AF5703E9-5759-4710-A554-CA5B16BFAB77 Q36071094-B0EF48F8-FB91-4B59-82F1-CAE8C74AA0C7 Q36655971-4EC6991B-D299-4ADF-9E63-DC4D18C8F93E Q36734036-D316CA5F-2279-41B9-838D-3C99A9B850AE Q36850145-4A866A39-1BE5-41B6-8027-9E52405BD11B Q37313299-6838F871-A35E-41A3-9699-5A0074DE196E Q37577156-4663CBE4-737F-4D04-898F-6CFA5831366F Q37629545-00F6CD1F-A6FA-4066-838B-8210A01DBB33 Q38002682-9E451115-B4CC-44F0-B8BE-5E253E912F61 Q38077536-AAD629FA-0729-4B49-8D4F-08C657E9892A Q38096735-A0C8C6AE-2E83-4D36-ADE0-FD5E649D26F7 Q38149124-3314B7C5-4209-469E-8474-DEB1E052BED8 Q38266059-03257E08-BCF4-4A10-BB2F-C72828A2989F Q38426514-CE7F085F-65BF-4E48-B828-1C2B67AF0879 Q38597093-C17EA553-25F9-47F4-99AE-7ABE26BDFF49 Q38728309-8D4875DF-766E-44BF-BA02-CA85F02F6791 Q38795318-3F9D38BD-8C24-4BE5-A811-C99EA24DA9CD Q38797560-4AB11CDC-5262-474F-89EF-4D4361D855EC Q38800777-ABBF2286-F5B3-4D83-9D18-FE27A937FB85 Q38821546-AF6E4F5B-6894-48CF-AD5D-C56909B0D681 Q38846866-97FD31FC-4484-4566-98BD-BE8C9253B3CA Q38846889-E3B0F31E-37E2-47EA-B62B-7194B30694F8 Q38968138-16D16B75-28AE-431E-886E-00C19652EEC1 Q39656931-BB53212A-D7D6-4A26-94AD-261B15C096C6 Q40021711-1AB981D4-7F43-4FF0-BEB0-8484B46A3E94 Q41139603-32198EE0-28E1-4E64-886B-83E5C7D65234

P2860

Impact of circulating cholesterol levels on growth and intratumoral androgen concentration of prostate tumors

http://www.wikidata.org/entity/Q34141720

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Impact of circulating choleste ...... ncentration of prostate tumors

@ast

Impact of circulating choleste ...... ncentration of prostate tumors

@en

Impact of circulating choleste ...... ncentration of prostate tumors

@nl

type

label

Impact of circulating choleste ...... ncentration of prostate tumors

@ast

Impact of circulating choleste ...... ncentration of prostate tumors

@en

Impact of circulating choleste ...... ncentration of prostate tumors

@nl

prefLabel

Impact of circulating choleste ...... ncentration of prostate tumors

@ast

Impact of circulating choleste ...... ncentration of prostate tumors

@en

Impact of circulating choleste ...... ncentration of prostate tumors

@nl

P1433

Q34141720-605F7010-4C5B-457F-AA15-86EEED9EBB00

P1476

Q34141720-0A109955-52B8-4926-9A24-290018988880

P2093

Q34141720-2726E790-082C-461F-89E8-BA3E0E436D13

Q34141720-3E8C3767-D38C-43A6-A0B9-E5B842537C7F

Q34141720-74F33524-7869-4EB8-8D56-AD5A81F815FB

Q34141720-AF72972E-EDFB-4BC3-9559-5BD2F3142CA4

Q34141720-D16F7980-274A-40B2-9DAE-564E639505AB

P2860

Q34141720-043F3F67-DA53-45B3-8003-AE17C1F973CB

Q34141720-0965232F-DB24-4C39-A51F-8F04B4B6F397

Q34141720-0B37AD30-D30D-46EF-9D68-31D4FCB53ED2

Q34141720-0F44F9E9-DD69-4FEB-9772-8E8DD8CD6900

Q34141720-172BB243-9B90-4A2E-B225-86E2AFDA7F3B

Q34141720-176F5C3A-2BA9-42AC-B37C-8336CA07EBCE

Q34141720-1ECE3EA6-DEF7-4D6D-9D21-35AA4656BD1D

Q34141720-23C510F3-8457-43AD-A3F8-E0D114BC5F7C

Q34141720-27FDE6B7-A168-45C6-A4DE-EE8327108EAE

Q34141720-372CFB41-B6A0-47D1-B79E-DC088551803E

P304

Q34141720-88632C9E-D522-442F-8C55-8F87DEB81A5D

P31

Q34141720-AF5A3ACD-F0CD-44D4-B4F0-807F4BF8C76B

P356

Q34141720-3331D8E7-1E68-4458-A99D-41CCB9E363D3

P407

Q34141720-FC643370-D5F1-4C5D-A795-FEA2D663C490

P433

Q34141720-AA103344-D1F4-453F-8094-93111063C89E

P478

Q34141720-48AE1CF8-19D4-4E2B-92EE-592090F59E1D

P577

Q34141720-30FC208A-124B-46FE-A39B-67BC74F10611

P5875

Q34141720-E0AF93E9-1E5D-4F1E-976D-D473E3228A1D

P698

Q34141720-9EAD2488-4E2F-445C-969B-3F5F074DBA47

P932

Q34141720-AD29D8F4-3A8D-4CD7-ADDA-9553554E7E7D

P356

JOURNAL.PONE.0030062

P1433

P1476

Impact of circulating choleste ...... ncentration of prostate tumors

@en

P2093

Elahe A Mostaghel

http://www.w3.org/2001/XMLSchema#string

Keith R Solomon

http://www.w3.org/2001/XMLSchema#string

Kristine Pelton

http://www.w3.org/2001/XMLSchema#string

Michael R Freeman

http://www.w3.org/2001/XMLSchema#string

R Bruce Montgomery

http://www.w3.org/2001/XMLSchema#string

P2860

Androgens repress the expression of the angiogenesis inhibitor thrombospondin-1 in normal and neoplastic prostate

Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption

Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

Lipid rafts as a membrane-organizing principle

Abiraterone and increased survival in metastatic prostate cancer

Dietary fat and prostate cancer: current status.

The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway.

Men with low serum cholesterol have a lower risk of high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial.

Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion.

P304

e30062

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0030062

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221779593

http://www.w3.org/2001/XMLSchema#string

P698

22279565

http://www.w3.org/2001/XMLSchema#string

P932

3261168

http://www.w3.org/2001/XMLSchema#string